search
Back to results

Pre Radiotherapy Daily Exercise Training in Non-Small Cell Lung Cancer (PRIME)

Primary Purpose

Non-Small Cell Lung Cancer Stage, Chemoradiation

Status
Active
Phase
Not Applicable
Locations
Denmark
Study Type
Interventional
Intervention
Exercise +
Control +
Sponsored by
Rigshospitalet, Denmark
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional supportive care trial for Non-Small Cell Lung Cancer Stage focused on measuring Aerobic exercise, Lung Cancer

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Patients with NSCLC who are treated with concomitant chemo- and radiotherapy.
  • Age: > 18 year
  • WHO performance status 0-1

Exclusion Criteria:

  • Patients with any symptoms or circumstances that advise against physical activity.
  • Symptomatic heart disease e.g. arrhythmia or myocardial infarction within the last three months.
  • Congestive heart failure
  • Patients who do not read and speak Danish.
  • Brain or bone metastases;
  • Prolonged bone marrow suppression
  • Anti-coagulant treatment
  • Inability to provide informed consent.

Sites / Locations

  • University Hospital of Copenhagen

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Experimental

Arm Label

Exercise + usual care

Control - usual care

Arm Description

The supervised exercise training is carried out on a ergometer cycle as individual daily (mon-fri) training and each exercise training session consists of 20min. The training comprised a warm-up phase followed by 3 exercise phases. Warm-up consisted of 5min light stationary cycling, adjusted to 50-60% of the patients peak power output determine at the incremental cycle test (iPPO). The first exercise phase comprised of 5min interval training consisting of 5x30 sec intervals at 80-95% of the patient's iPPO. Between each interval, there is a 30 sec pause. The 2nd exercise phase consisted of 5min continuous cycling at an intensity equaling 80% of the patient's iPPO. The 3rd exercise phase was similar to the first exercise phase. Intensities increased progressively from the first week to the last week (from 50%, 80% and 70% of iPPO according to the three different phases to 60%, 95% and 80 % of iPPO respectively.

The patients randomized to the control group received no training but will be wearing the activity tracker during the intervention.

Outcomes

Primary Outcome Measures

Maximum oxygen uptake - VO2peak
The primary outcome will be VO2peak, assessed with an aerobic capacity (VO2peak) incremental cycle ergometer test performed on a Monark ergometer 839E cycle. At baseline, human physiology students will carry out the incremental cycle test. A physiotherapist who is blinded to the groups wherein the patients are allocated will carry out the posttest. The test consist of a warm-up phase at 10-50 w. After warm-up the load increases by 5-10 w every 60 sec until exhaustion or a possible symptom limitation (e.g. dizziness, sudden pain, vomiting sensation). To analyze the expired gases patients are going to wear a Hans Rudolf Mask during the test. Expired gases will be analyzed continuously by a metabolic breath-by-breath analysis and calculated as an average over 15 sec using the Oxycon Pro. Jaeger measurement system.

Secondary Outcome Measures

Functional capacity
Functional capacity is measured by a 6 MWD test. The test is carried out over a pre-measured distance of 20 meters, in compliance with the American Thoracic Society (ATS) statement. After the test the patients will rate the breathing on Borg Scale for dyspnea.
Forced Expiratory Volume in one second
Forced Expiratory Volume in 1 second (FEV1) is measured using a standard spirometry in a standing position with the use of the Oxycon Pro, Jaeger measurement system.
Lung Function
Ventilation (VE), Breath frekvens (BF) and tidal volume (Vt) measured by indirect calorimetry.
Hypoxia in tumor
The extent of hypoxia in human tumors assessed by dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI).
Stroke volumen
Stroke volumen will be measured by a ClearSight System
Cardiac output
Cardiac output will be measured by a ClearSight System
Systemic vascular resistance
Systemic vascular resistance (SVR) will be measured by a ClearSight System
Safety: Sports-injury, Pain, Neuropathies, Nausea/vomiting, Fatigue etc.
Serious adverse events and adverse events (e.g.)sports-injury, pain, neuropathies, nausea/vomiting, fatigue, neutropenia, fever, diarrhoea, hospitalisation and infection
Respiratory exchange ratio (RER)
To analyze the expired gases patients are going to wear a Hans Rudolf Mask during a incremental cycle ergometer test. Expired gases will be analyzed continuously by a metabolic breath-by-breath analysis and calculated as an average over 15 seconds using the Oxycon Pro. Jaeger measurement system.
Rated Perceived Exertion (RPE) Scale
In the final seconds of the incremental cycle ergometer test self-perceived exertion perception and dyspnoea will be noted.

Full Information

First Posted
February 8, 2017
Last Updated
March 27, 2023
Sponsor
Rigshospitalet, Denmark
Collaborators
University of Copenhagen
search

1. Study Identification

Unique Protocol Identification Number
NCT03066271
Brief Title
Pre Radiotherapy Daily Exercise Training in Non-Small Cell Lung Cancer
Acronym
PRIME
Official Title
PRIME - Pre Radiotherapy Daily Exercise Training in Non-Small Cell Lung Cancer
Study Type
Interventional

2. Study Status

Record Verification Date
October 2022
Overall Recruitment Status
Active, not recruiting
Study Start Date
April 3, 2017 (Actual)
Primary Completion Date
December 31, 2023 (Anticipated)
Study Completion Date
December 31, 2023 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Rigshospitalet, Denmark
Collaborators
University of Copenhagen

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The aim of this study is to evaluate the feasibility and the effect of daily, individual, supervised and structured exercise training before radiotherapy in patients diagnosed with Non-Small Cell Lung Cancer. Primary outcome is maximal oxygen uptake (VO2peak). The hypotheses are that patients who undergo daily exercise training will increase VO2peak, functional capacity (measured by 6-minute walk test (6MWD)) and lung function (forced expired volume in one second (FEV1)).
Detailed Description
Pre intervention screening: Each patient was screened by a clinical nurse specialist prior to participating in the study. Before baseline and post test the patient was screened by a research physiotherapist and/or human physiology students. If one of the following criteria were met, the patient was prohibited from being tested on that day: diastolic blood pressure <45 or >95, heart rate (HR) at rest >115/min, temperature > 38 0C, respiratory rate at rest >30/min, infection requiring treatment, fresh bleeding, total leucocyte count <1.0 109/L or platelets <50 109/L. Control - Usual care: The patients randomized to the control group received no training but conducted baseline and post test (6MWD, spirometry, VO2peak and questionnaires) just as the intervention group. Furthermore, patients in control were equipped with a Garmin vivo-smart HR® activity tracker every day in 24h during the course of radiotherapy treatment. Intervention - The patients randomized to the intervention group received daily training and conducted baseline and post test (6MWD, spirometry, VO2peak and questionnaires). Furthermore, patients were equipped with a Garmin vivo-smart HR® activity tracker every day in 24h during the course of radiotherapy treatment. The supervised daily training was carried out individually and each session had a duration of 20 minutes before patients individual prescribed radiotherapy. Training was conducted at National Hospital of Denmark: Department of Radiation Oncology , section 3981, entry 39. supervised by a research physiotherapist and/or human physiology students. Statistical analysis sample size: According to the sample size the calculation is performed on the basis of alteration in VO2peak from the study "EXHALE" (55 patients who completed a 6 weeks training period). The calculation is based on an increase of 200 ml/min in VO2peak for patients in the intervention group (SD = 2,48) and it is assumed that the patients in the control group will have a reduction of 100 ml/min (SD = 2,48). Assumptions for calculation of patient numbers are as follows: Type 1 error 0.05, type 2 error 0.20, SD 2.48. This leads to a total number of 24 patients (12 in each arm). A drop-out rate of 40% is included. Therefore another 16 patients is added, which gives a sample size of 40 patients (20 in each arm). Data entry is carried out in the Open Clinica and data analyses will be performed using the computer programs R-Studio/R and SPSS. Data from questionnaires will be analyzed by SPSS. All other data will be analyzed by R. Differences between groups will be analyzed by an unparried t-test whereas differences within groups will be analyzed by a parried t-test. All categorical data are analyzed using the Pearson χ2 tests. Other data (e.g., from questionnaires) are analyzed using logistic regression and chi square or Mantel Haenzel test. Significance level is set at 0.05.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Non-Small Cell Lung Cancer Stage, Chemoradiation
Keywords
Aerobic exercise, Lung Cancer

7. Study Design

Primary Purpose
Supportive Care
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Investigator
Allocation
Randomized
Enrollment
40 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Exercise + usual care
Arm Type
Experimental
Arm Description
The supervised exercise training is carried out on a ergometer cycle as individual daily (mon-fri) training and each exercise training session consists of 20min. The training comprised a warm-up phase followed by 3 exercise phases. Warm-up consisted of 5min light stationary cycling, adjusted to 50-60% of the patients peak power output determine at the incremental cycle test (iPPO). The first exercise phase comprised of 5min interval training consisting of 5x30 sec intervals at 80-95% of the patient's iPPO. Between each interval, there is a 30 sec pause. The 2nd exercise phase consisted of 5min continuous cycling at an intensity equaling 80% of the patient's iPPO. The 3rd exercise phase was similar to the first exercise phase. Intensities increased progressively from the first week to the last week (from 50%, 80% and 70% of iPPO according to the three different phases to 60%, 95% and 80 % of iPPO respectively.
Arm Title
Control - usual care
Arm Type
Experimental
Arm Description
The patients randomized to the control group received no training but will be wearing the activity tracker during the intervention.
Intervention Type
Other
Intervention Name(s)
Exercise +
Intervention Description
Usual care
Intervention Type
Other
Intervention Name(s)
Control +
Intervention Description
Usual care
Primary Outcome Measure Information:
Title
Maximum oxygen uptake - VO2peak
Description
The primary outcome will be VO2peak, assessed with an aerobic capacity (VO2peak) incremental cycle ergometer test performed on a Monark ergometer 839E cycle. At baseline, human physiology students will carry out the incremental cycle test. A physiotherapist who is blinded to the groups wherein the patients are allocated will carry out the posttest. The test consist of a warm-up phase at 10-50 w. After warm-up the load increases by 5-10 w every 60 sec until exhaustion or a possible symptom limitation (e.g. dizziness, sudden pain, vomiting sensation). To analyze the expired gases patients are going to wear a Hans Rudolf Mask during the test. Expired gases will be analyzed continuously by a metabolic breath-by-breath analysis and calculated as an average over 15 sec using the Oxycon Pro. Jaeger measurement system.
Time Frame
Change from baseline at 7 weeks
Secondary Outcome Measure Information:
Title
Functional capacity
Description
Functional capacity is measured by a 6 MWD test. The test is carried out over a pre-measured distance of 20 meters, in compliance with the American Thoracic Society (ATS) statement. After the test the patients will rate the breathing on Borg Scale for dyspnea.
Time Frame
Baseline and 7 weeks
Title
Forced Expiratory Volume in one second
Description
Forced Expiratory Volume in 1 second (FEV1) is measured using a standard spirometry in a standing position with the use of the Oxycon Pro, Jaeger measurement system.
Time Frame
Baseline and 7 weeks
Title
Lung Function
Description
Ventilation (VE), Breath frekvens (BF) and tidal volume (Vt) measured by indirect calorimetry.
Time Frame
Baseline and 7 weeks
Title
Hypoxia in tumor
Description
The extent of hypoxia in human tumors assessed by dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI).
Time Frame
Baseline and 7 weeks
Title
Stroke volumen
Description
Stroke volumen will be measured by a ClearSight System
Time Frame
Baseline, selected test samples during training intervention and 7 weeks
Title
Cardiac output
Description
Cardiac output will be measured by a ClearSight System
Time Frame
Baseline, selected test samples during training intervention and 7 weeks
Title
Systemic vascular resistance
Description
Systemic vascular resistance (SVR) will be measured by a ClearSight System
Time Frame
Baseline, selected test samples during training intervention and 7 weeks
Title
Safety: Sports-injury, Pain, Neuropathies, Nausea/vomiting, Fatigue etc.
Description
Serious adverse events and adverse events (e.g.)sports-injury, pain, neuropathies, nausea/vomiting, fatigue, neutropenia, fever, diarrhoea, hospitalisation and infection
Time Frame
Baseline, during intervention and 7 weeks
Title
Respiratory exchange ratio (RER)
Description
To analyze the expired gases patients are going to wear a Hans Rudolf Mask during a incremental cycle ergometer test. Expired gases will be analyzed continuously by a metabolic breath-by-breath analysis and calculated as an average over 15 seconds using the Oxycon Pro. Jaeger measurement system.
Time Frame
Change from baseline at 7 weeks
Title
Rated Perceived Exertion (RPE) Scale
Description
In the final seconds of the incremental cycle ergometer test self-perceived exertion perception and dyspnoea will be noted.
Time Frame
Change from baseline at 7 weeks
Other Pre-specified Outcome Measures:
Title
Overall survival rate
Description
Overall survival be measured from inclusion until death or 26 weeks or 52 weeks
Time Frame
26 weeks and 52 weeks
Title
Physical Activity
Description
Physical Activity - International Physical Activity Questionnaire Long (IPAQ-L).
Time Frame
Change from baseline at 7 weeks
Title
Quality of life and wellbeing
Description
Quality of life and wellbeing - Functional Assessment of Cancer Therapy - Lung (FACT-L).
Time Frame
Change from baseline at 7 weeks
Title
Anxiety and depression
Description
Anxiety and depression - Hospital Anxiety and Depression Scale (HAD)
Time Frame
Change from baseline at 7 weeks
Title
Activity Data
Description
Steps, distance and intensity minutes measured by Garmin vivo-smart HR® activity tracker.
Time Frame
Every day in 24h during the course of radiotherapy treatment

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Patients with NSCLC who are treated with concomitant chemo- and radiotherapy. Age: > 18 year WHO performance status 0-1 Exclusion Criteria: Patients with any symptoms or circumstances that advise against physical activity. Symptomatic heart disease e.g. arrhythmia or myocardial infarction within the last three months. Congestive heart failure Patients who do not read and speak Danish. Brain or bone metastases; Prolonged bone marrow suppression Anti-coagulant treatment Inability to provide informed consent.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Morten Quist, Post. doc
Organizational Affiliation
Rigshospitalet, Denmark
Official's Role
Principal Investigator
Facility Information:
Facility Name
University Hospital of Copenhagen
City
Copenhagen
ZIP/Postal Code
2100
Country
Denmark

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Pre Radiotherapy Daily Exercise Training in Non-Small Cell Lung Cancer

We'll reach out to this number within 24 hrs